Cargando…

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13

Fungal infections caused by Candida spp. represent an emerging problem during treatment of immunocompromised patients and those hospitalized with serious principal diseases. The ever-growing number of fungal strains exhibiting drug resistance necessitates the development of novel antimicrobial thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niemirowicz, Katarzyna, Durnaś, Bonita, Tokajuk, Grażyna, Piktel, Ewelina, Michalak, Grzegorz, Gu, Xiaobo, Kułakowska, Alina, Savage, Paul B., Bucki, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496903/ https://www.ncbi.nlm.nih.gov/pubmed/28676673 http://dx.doi.org/10.1038/s41598-017-04653-1

Ejemplares similares

Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
por: Durnaś, Bonita, et al.
Publicado: (2016)

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo
por: Durnaś, Bonita, et al.
Publicado: (2017)

Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
por: Niemirowicz, Katarzyna, et al.
Publicado: (2016)

Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis
por: Piktel, Ewelina, et al.
Publicado: (2017)

Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents
por: Skłodowski, Karol, et al.
Publicado: (2021)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection
por: Wnorowska, Urszula, et al.
Publicado: (2022)

Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles
por: Niemirowicz, Katarzyna, et al.
Publicado: (2015)

Use of ceragenins as a potential treatment for urinary tract infections
por: Wnorowska, Urszula, et al.
Publicado: (2019)

Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells
por: Niemirowicz, Katarzyna, et al.
Publicado: (2015)

NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
por: Chmielewska, Sylwia Joanna, et al.
Publicado: (2020)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
por: Wnorowska, Urszula, et al.
Publicado: (2020)

Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells
por: Piktel, Ewelina, et al.
Publicado: (2020)

Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance
por: Piktel, Ewelina, et al.
Publicado: (2018)

Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections
por: Karasiński, Maciej, et al.
Publicado: (2023)

Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
por: Leszczyńska, Katarzyna, et al.
Publicado: (2009)

Ceragenin CSA-44 as a Means to Control the Formation of the Biofilm on the Surface of Tooth and Composite Fillings
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells
por: Wollny, Tomasz, et al.
Publicado: (2022)

Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains
por: Chmielewska, Sylwia Joanna, et al.
Publicado: (2021)

Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model
por: Piktel, Ewelina, et al.
Publicado: (2021)

Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen Stenotrophomonas maltophilia
por: Paprocka, Paulina, et al.
Publicado: (2022)

Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease
por: Wollny, Tomasz, et al.
Publicado: (2017)

Glyoxylate Shunt and Pyruvate-to-Acetoin Shift Are Specific Stress Responses Induced by Colistin and Ceragenin CSA-13 in Enterobacter hormaechei ST89
por: Prasad, Suhanya V., et al.
Publicado: (2023)

Assessment of Ceragenins in Prevention of Damage to Voice Prostheses Caused by Candida Biofilm Formation
por: Spałek, Jakub, et al.
Publicado: (2021)

Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity
por: Tokajuk, Grażyna, et al.
Publicado: (2017)

Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
por: Piktel, Ewelina, et al.
Publicado: (2018)

Antibacterial and Antifungal Activities of Poloxamer Micelles Containing Ceragenin CSA-131 on Ciliated Tissues
por: Hashemi, Marjan M., et al.
Publicado: (2018)

New β-Lactam Antibiotics and Ceragenins – A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa
por: Paprocka, Paulina, et al.
Publicado: (2021)

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
por: Simonetti, Oriana, et al.
Publicado: (2021)

Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines
por: Niemirowicz-Laskowska, Katarzyna, et al.
Publicado: (2018)

Susceptibility of microbial cells to the modified PIP(2)-binding sequence of gelsolin anchored on the surface of magnetic nanoparticles
por: Bucki, Robert, et al.
Publicado: (2019)

Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics
por: Bucki, Robert, et al.
Publicado: (2018)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Transformation of Human Cathelicidin LL-37 into Selective, Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014)

Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi’s sarcoma
por: Fathy, Hanan, et al.
Publicado: (2012)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
por: Guo, Yi-jie, et al.
Publicado: (2016)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mfqlul7r4ec1sjqfe319eb1u01